The significance of the nitric oxide in electro-convulsive therapy: A proposed neurophysiological mechanism

Yitzhak Rosen, Ilya Reznik, Ariel Sluvis, Desmond Kaplan, Roberto Mester

Research output: Contribution to journalReview article

Abstract

Electroconvulsive therapy (ECT) is used to treat patients with major depressive disorder, manic episodes and other serious mental disorders. Virtually every neurotransmitter system is affected in ECT. The significance of the nitric oxide (NO), which has an established role as a neurotransmitter, neuromodulator, and an intraneuronal second messenger, in ECT is still not clear. We described the involvement of NO in long-term potentiation, the N-methyl-D-aspartic acid (NMDA) receptor activity, regulation of cerebral blood flow, and the hypothalamic-pituitary axis and propose that this involvement is critical in ECT's efficiency, treatment refractoriness, and neuropsychological sequelae by its influences on these systems. Nitric oxide's significant role in other pathophysiological mechanisms has led to current therapeutic protocols and may be applicable in this setting.

Original languageEnglish (US)
Pages (from-to)424-429
Number of pages6
JournalMedical Hypotheses
Volume60
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Convulsive Therapy
Electroconvulsive Therapy
Neurotransmitter Agents
Nitric Oxide
Cerebrovascular Circulation
Long-Term Potentiation
Major Depressive Disorder
Second Messenger Systems
N-Methylaspartate
Mental Disorders
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The significance of the nitric oxide in electro-convulsive therapy : A proposed neurophysiological mechanism. / Rosen, Yitzhak; Reznik, Ilya; Sluvis, Ariel; Kaplan, Desmond; Mester, Roberto.

In: Medical Hypotheses, Vol. 60, No. 3, 01.03.2003, p. 424-429.

Research output: Contribution to journalReview article

@article{a69dd8d8b6a34184b075fffe57e4d9d4,
title = "The significance of the nitric oxide in electro-convulsive therapy: A proposed neurophysiological mechanism",
abstract = "Electroconvulsive therapy (ECT) is used to treat patients with major depressive disorder, manic episodes and other serious mental disorders. Virtually every neurotransmitter system is affected in ECT. The significance of the nitric oxide (NO), which has an established role as a neurotransmitter, neuromodulator, and an intraneuronal second messenger, in ECT is still not clear. We described the involvement of NO in long-term potentiation, the N-methyl-D-aspartic acid (NMDA) receptor activity, regulation of cerebral blood flow, and the hypothalamic-pituitary axis and propose that this involvement is critical in ECT's efficiency, treatment refractoriness, and neuropsychological sequelae by its influences on these systems. Nitric oxide's significant role in other pathophysiological mechanisms has led to current therapeutic protocols and may be applicable in this setting.",
author = "Yitzhak Rosen and Ilya Reznik and Ariel Sluvis and Desmond Kaplan and Roberto Mester",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S0306-9877(02)00419-X",
language = "English (US)",
volume = "60",
pages = "424--429",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - The significance of the nitric oxide in electro-convulsive therapy

T2 - A proposed neurophysiological mechanism

AU - Rosen, Yitzhak

AU - Reznik, Ilya

AU - Sluvis, Ariel

AU - Kaplan, Desmond

AU - Mester, Roberto

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Electroconvulsive therapy (ECT) is used to treat patients with major depressive disorder, manic episodes and other serious mental disorders. Virtually every neurotransmitter system is affected in ECT. The significance of the nitric oxide (NO), which has an established role as a neurotransmitter, neuromodulator, and an intraneuronal second messenger, in ECT is still not clear. We described the involvement of NO in long-term potentiation, the N-methyl-D-aspartic acid (NMDA) receptor activity, regulation of cerebral blood flow, and the hypothalamic-pituitary axis and propose that this involvement is critical in ECT's efficiency, treatment refractoriness, and neuropsychological sequelae by its influences on these systems. Nitric oxide's significant role in other pathophysiological mechanisms has led to current therapeutic protocols and may be applicable in this setting.

AB - Electroconvulsive therapy (ECT) is used to treat patients with major depressive disorder, manic episodes and other serious mental disorders. Virtually every neurotransmitter system is affected in ECT. The significance of the nitric oxide (NO), which has an established role as a neurotransmitter, neuromodulator, and an intraneuronal second messenger, in ECT is still not clear. We described the involvement of NO in long-term potentiation, the N-methyl-D-aspartic acid (NMDA) receptor activity, regulation of cerebral blood flow, and the hypothalamic-pituitary axis and propose that this involvement is critical in ECT's efficiency, treatment refractoriness, and neuropsychological sequelae by its influences on these systems. Nitric oxide's significant role in other pathophysiological mechanisms has led to current therapeutic protocols and may be applicable in this setting.

UR - http://www.scopus.com/inward/record.url?scp=0037372522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037372522&partnerID=8YFLogxK

U2 - 10.1016/S0306-9877(02)00419-X

DO - 10.1016/S0306-9877(02)00419-X

M3 - Review article

C2 - 12581624

AN - SCOPUS:0037372522

VL - 60

SP - 424

EP - 429

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 3

ER -